Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;11(1):1-8.
doi: 10.21053/ceo.2017.00717. Epub 2018 Feb 22.

Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis

Affiliations

Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis

Bo Hae Kim et al. Clin Exp Otorhinolaryngol. 2018 Mar.

Abstract

Objectives: This study compared the survival outcomes, local control rate, and laryngeal preservation rate of various treatment strategies in the treatment of T3 squamous cell carcinoma of the glottis using proportional meta-analyses.

Methods: Twenty-five retrospective case-series studies were included in these analyses. Treatment strategies were classified as total laryngectomy (TL), open partial laryngectomy (PL), transoral laser microsurgery (TLM), chemo-radiation therapy (CRT), and radiation therapy (RT) alone.

Results: The overall survival rate and disease-specific survival rate among laryngeal preservation treatments did not differ from the overall survival rate of TL. However, the local control rate was lower with RT than TL and PL, and laryngeal preservation rates of TLM and CRT were higher than RT alone.

Conclusion: Consideration of preservation of laryngeal function is necessary when treating T3 glottic squamous cell carcinoma. PL, TLM, and, CRT are considered more appropriate initial laryngeal preservation strategies if available.

Keywords: Glottis; Meta-Analysis; Organ Preservation; Squamous Cell Carcinoma; Survival.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Flow chart of studies through the review.
Fig. 2.
Fig. 2.
A proportional meta-analysis of case series studies comparing overall survival rate after primary treatments in patients with T3 glottic squamous cell carcinoma.
Fig. 3.
Fig. 3.
A proportional meta-analysis of case series studies comparing disease-specific survival rate after primary treatments in patients with T3 glottic squamous cell carcinoma.
Fig. 4.
Fig. 4.
A proportional meta-analysis of case series studies comparing local control rate after primary treatments in patients with T3 glottic squamous cell carcinoma.
Fig. 5.
Fig. 5.
A proportional meta-analysis of case series studies comparing laryngeal preservation rate after primary treatments in patients with T3 glottic squamous cell carcinoma.

Similar articles

Cited by

References

    1. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006 Sep;116(9 Pt 2 Suppl 111):1–13. - PubMed
    1. Department of Veterans Affairs Laryngeal Cancer Study Group. Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991 Jun;324(24):1685–90. - PubMed
    1. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013 Mar;31(7):845–52. - PMC - PubMed
    1. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981 Oct;305(17):982–7. - PubMed
    1. Fu X, Zhou Q, Zhang X. Efficacy comparison between total laryngectomy and nonsurgical organ-preservation modalities in treatment of advanced stage laryngeal cancer: a meta-analysis. Medicine (Baltimore) 2016 Apr;95(14):e3142. - PMC - PubMed